Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at AED 503.8B, ahead of Pfizer (AED 445.8B) and Johnson & Johnson (AED 432.1B). Figures as of 18 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieAED 503.8B
- Median
- AED 7.7B
- Combined market value
- AED 18.94T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | AED 503.8B | AED 1.9T | AED 1,075.35 | 0.59% down | 26% up | ||
| 2 | PfizerPFE · Health Care | AED 445.8B | AED 595.9B | AED 104.55 | 1.35% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | AED 432.1B | AED 2.46T | AED 1,023.50 | 1.36% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | AED 315.6B | AED 4.63T | AED 5,198.47 | 1.13% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | AED 309.2B | AED 1.3T | AED 526.51 | 0.75% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | AED 262.7B | AED 460.5B | AED 225.30 | 2.51% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | AED 240B | AED 1.04T | AED 669.37 | 0.95% down | 2% up | ||
| 8 | NovartisNVS · Health Care | AED 236.5B | AED 1.1T | AED 584.39 | 0.67% down | 25% up | ||
| 9 | SanofiSNY · Health Care | AED 224.5B | AED 419.1B | AED 174.55 | 1.78% down | 4% down | ||
| 10 | GSKGSK · Health Care | AED 220.1B | AED 362.5B | AED 180.83 | 2.32% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | AED 190.1B | AED 658.8B | AED 149.47 | 2.16% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | AED 185.9B | AED 253.9B | AED 79.47 | 0.23% up | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | AED 124.6B | AED 666B | AED 384.54 | 2.55% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 120.6B | AED 182.6B | AED 156.52 | 0.12% up | 74% up | ||
| 15 | ViatrisVTRS · Health Care | AED 82.6B | AED 86.1B | AED 75.10 | 1.40% down | 96% up | ||
| 16 | GrifolsGRFS · Health Care | AED 49.3B | AED 21.6B | AED 31.69 | 1.15% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | AED 44.6B | AED 124.6B | AED 306.57 | 1.08% down | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | AED 36.4B | AED 145B | AED 252.22 | 0.23% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | AED 34.2B | AED 363.9B | AED 3,517.28 | 0.56% up | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | AED 27B | AED 56.7B | AED 883.98 | 0.39% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | AED 25.8B | AED 117.7B | AED 190.82 | 0.76% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | AED 25.6B | AED 497.4B | AED 1,961.80 | 0.67% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | AED 25B | AED 47.4B | AED 94.93 | 2.12% down | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | AED 15.3B | AED 77B | AED 574.73 | 2.02% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | AED 14.1B | AED 173.4B | AED 1,517.66 | 0.48% up | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | AED 13.5B | AED 27B | AED 77.56 | 0.52% down | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | AED 11.4B | AED 18.5B | AED 221.67 | 1.00% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | AED 11.1B | AED 16.5B | AED 99.01 | 3.75% down | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | AED 11.1B | AED 54.9B | AED 282.04 | 0.72% down | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 7.8B | AED 45.3B | AED 54.31 | 0.61% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | AED 7.7B | AED 26.4B | AED 189.68 | 2.86% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | AED 6B | AED 65.3B | AED 995.92 | 0.20% down | 28% up | ||
| 33 | InsmedINSM · Health Care | AED 5.6B | AED 98.2B | AED 447.52 | 0.83% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | AED 5.5B | AED 41.6B | AED 214.87 | 0.90% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | AED 3.2B | AED 22.3B | AED 157.88 | 2.76% down | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | AED 2.9B | AED 91.4B | AED 2,145.05 | 0.64% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | AED 2.7B | AED 11.5B | AED 59.16 | 0.75% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | AED 2.5B | AED 28B | AED 166.91 | 2.32% down | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | AED 2.4B | AED 36B | AED 1,549.72 | 0.46% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | AED 2.2B | AED 26.3B | AED 499.26 | 0.77% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | AED 2B | AED 21.6B | AED 1,078.99 | 2.62% down | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | AED 1.9B | AED 22B | AED 337.68 | 0.40% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | AED 1.8B | AED 18B | AED 187.66 | 2.82% up | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | AED 1.5B | AED 103B | AED 142.16 | 0.26% up | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | AED 1.5B | AED 34.8B | AED 230.30 | 0.08% down | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | AED 1.1B | AED 17.8B | AED 102.28 | 1.49% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | AED 771.8M | AED 29.7B | AED 428.24 | 8.49% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 719.9M | AED 27.4B | AED 349.28 | 0.93% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | AED 693.5M | AED 28.2B | AED 257.33 | 1.23% up | 8% down | ||
| 50 | ABIVAXABVX · Health Care | AED 526.2M | AED 26.4B | AED 301.50 | 1.81% down | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | AED 395.8M | AED 14.8B | AED 107.90 | 2.59% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | AED 339M | AED 31.3B | AED 39.18 | 9.73% down | 36% down | ||
| 53 | ErascaERAS · Health Care | AED 260.7M | AED 17.9B | AED 51.01 | 8.07% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | AED 229.7M | AED 32.7B | AED 344.51 | 5.60% down | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | AED 219.5M | AED 31.3B | AED 1,120.30 | 1.68% down | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | AED 196.4M | AED 29.9B | AED 457.84 | 0.13% down | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | AED 137.8M | AED 18B | AED 319.43 | 2.87% down | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | AED 111.4M | AED 16.9B | AED 154.39 | 3.75% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | AED 61.3M | AED 24B | AED 353.73 | 2.94% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | AED 37M | AED 23.5B | AED 579.21 | 2.98% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | AED 33.6M | AED 19.5B | AED 461.40 | 1.88% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6724 AED).
Questions and answers
Which pharmaceuticals rank first by total liabilities?
AbbVie (AED 503.8B), Pfizer (AED 445.8B) and Johnson & Johnson (AED 432.1B) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 18 Nov 2026, 14:23 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of AED 18.94T as of 18 Nov 2026, 14:23 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.